DR-02

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDR-02

Drug Alias NameDR-02

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsSolid tumoursHematologic NeoplasmsImmunoglobulin Light-chain Amyloidosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesDren Bio Inc

China Registration ClassN/A

Develop Information

Active CompaniesDren Bio Inc

Inactive CompaniesN/A

Active IndicationsSolid tumoursHematologic NeoplasmsImmunoglobulin Light-chain Amyloidosis

Inactive IndicationsN/A

Other Information

ATC CodeN/A